---
audienceLevel: patient
cancerTypes:
- breast
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Margetuximab-cmkb - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/margetuximab-cmkb
version: v1
---

# Margetuximab-cmkb - NCI

# Margetuximab-cmkb

Placeholder slot

(MAR-jeh-TUK-sih-mab)

Margetuximab-cmkb works by binding to HER2, a protein found in high levels on some cancer cells and causes them to grow. Margetuximab-cmkb blocks the activity of HER2 and triggers a type of immune reaction that kills cells that have a lot of HER2. It is a type of targeted therapy drug called a monoclonal antibody.

US Brand Name(s)

Margenza

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e97a5872-eabf-463b-8f4c-5b5aed9c7bf0&audience=consumer)

## Use in Cancer

Margetuximab-cmkb
is approved to be used with [chemotherapy](/Common/PopUps/popDefinition.aspx?id=45214&version=Patient&language=English) to treat:

- **[breast cancer](/Common/PopUps/popDefinition.aspx?id=444971&version=Patient&language=English)** that is [HER2 positive](/Common/PopUps/popDefinition.aspx?id=737998&version=Patient&language=English) (HER2+) and has [metastasized](/Common/PopUps/popDefinition.aspx?id=46283&version=Patient&language=English) (spread to other parts of the body). It is used in adults who have received two or more anti-HER2 treatments, including at least one for metastatic disease.

Margetuximab-cmkb
is also being studied in the treatment of other types of
cancer.

## More About Margetuximab-cmkb

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/681010) - Detailed scientific definition and other names for this drug.

MedlinePlus Information on [Margetuximab-cmkb](https://medlineplus.gov/druginfo/meds/a621004.html) - A lay language summary of important information about this drug that may include the following:

- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

## Research Results and Related Resources

[Targeted Therapy to Treat Cancer](https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies)

[Monoclonal Antibodies](https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/monoclonal-antibodies)

## Clinical Trials Accepting Patients

[Find Clinical Trials for Margetuximab-cmkb](https://www.cancer.gov/research/participate/clinical-trials/intervention/C91733) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
